About Danopharm Chemicals
Danopharm Chemicals is a Healthcare company based in Andheri (India) founded in 1986. It manufactures high-quality bulk drugs and pharmaceutical intermediates. It operates on a B2B model. The company has 85 employees. Its Indian entity Danopharm Private Limited reported revenue of ₹109 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and Bulk Drugs. Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.
Company details
Danopharm Chemicals manufactures high-quality bulk drugs and pharmaceutical intermediates, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and bulk drugs. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Andheri, India
- Employees 85
- SectorsHealthcare
- Website danopharm.com
- Legal Name Danopharm Private Limited
- Date of Incorporation 15 Jan, 2009
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹109 Cr
FY 2025 · -7% YoY
- Net Profit₹6.52 Cr
FY 2025 · 6% margin
- EBITDA₹12.38 Cr
FY 2025 · 11% margin
- Employee Count85
Associated legal entities of Danopharm Chemicals
Danopharm Chemicals is associated with 2 registered companies on The Company Check; the primary company is Danopharm Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Danopharm Private Limited CIN U24100MH2009PTC189592 | Active | 15 Jan 2009 | Mumbai, Maharashtra | ₹109 Cr | 85 | 8 | View details |
| Synergy Health Sciences Private Limited CIN U24239MH2007PTC173718 | Active | 01 Sep 2007 | Thane, Maharashtra | ₹121 Cr | – | 5 | View details |
Board of directors of Danopharm Private Limited (Danopharm Chemicals)
Danopharm Private Limited is the primary company behind Danopharm Chemicals. The boards of the 2 registered companies of Danopharm Chemicals currently have 9 directors; the longest-serving is Sadhana Satish Nachane, appointed in 2007. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sadhana Satish Nachane DIN 01669985 | Director | 01 Sep 2007 | 19 yrs 1 mo | Synergy Health Sciences Private Limited |
| Jayanta Badalchandra Das DIN 02352513 | Director | 15 Jan 2009 | 17 yrs 9 mo | Danopharm Private Limited |
| Kamlesh Badal Das DIN 02352515 | Director | 15 Jan 2009 | 17 yrs 9 mo | Danopharm Private Limited |
| Kashinath Badal Das DIN 02428770 | Director | 15 Jan 2009 | 17 yrs 9 mo | Danopharm Private Limited |
| Bimlesh Badalchandra Das DIN 01246697 | Director | 15 Jan 2009 | 17 yrs 9 mo | Danopharm Private Limited |
| Satish Prabhakar Nachane DIN 00005520 | Director | 03 Sep 2009 | 17 yrs 1 mo | Danopharm Private Limited, Synergy Health Sciences Private Limited |
| Mehul Satish Nachane DIN 01669975 | Director | 03 Sep 2009 | 17 yrs 1 mo | Danopharm Private Limited, Synergy Health Sciences Private Limited |
| Ramesh Eknath Jadhav DIN 01984279 | Director | 16 Mar 2010 | 16 yrs 7 mo | Danopharm Private Limited, Synergy Health Sciences Private Limited |
| Sabu Daniel DIN 01984280 | Director | 16 Mar 2010 | 16 yrs 7 mo | Danopharm Private Limited, Synergy Health Sciences Private Limited |
People of Danopharm Chemicals
1 people are tracked at Danopharm Chemicals (1 in leadership); the tracked headcount is 85.
| Name | Role | Group |
|---|---|---|
| Proprietor | Leadership |
Complete people profiles for Danopharm Chemicals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Danopharm Chemicals
Figures of Danopharm Private Limited, the primary company behind Danopharm Chemicals, for FY 2025. Revenue was ₹109 Cr (-7% year on year). Net profit was ₹6.52 Cr (6% margin). EBITDA was ₹12.38 Cr (11% margin). Revenue has grown at a compounded annual rate of -6% over three years and +11% over five years.
- ₹109 CrRevenue · FY 2025 · -7% YoY
- ₹6.52 CrNet profit · 6% margin
- ₹12.38 CrEBITDA · 11% margin
- ₹2.00 CrPaid-up capital
- 85Employees (provident fund records)
- -6%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Danopharm Private Limited are on its company page.
Detailed financial statements for Danopharm Chemicals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Danopharm Chemicals
Danopharm Chemicals has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed similar companies of Danopharm Chemicals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Danopharm Chemicals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Danopharm Chemicals
Danopharm Chemicals was founded in 1986.
Danopharm Chemicals is headquartered in Andheri, India. It is registered at Andheri, Maharashtra, India.
Danopharm Chemicals has 85 employees.
The primary company behind Danopharm Chemicals, Danopharm Private Limited, reported revenue of ₹109 Cr for FY 2025, down 7% year on year.
Danopharm Chemicals manufactures high-quality bulk drugs and pharmaceutical intermediates, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and bulk drugs. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Danopharm Chemicals's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Danopharm Chemicals is associated with 2 legal entities: Danopharm Private Limited, Synergy Health Sciences Private Limited.
The legal entities of Danopharm Chemicals currently have 9 directors, including Jayanta Badalchandra Das, Kamlesh Badal Das, Satish Prabhakar Nachane and others.